THIOSULFIL Drug Patent Profile
✉ Email this page to a colleague
When do Thiosulfil patents expire, and when can generic versions of Thiosulfil launch?
Thiosulfil is a drug marketed by Wyeth Ayerst and is included in one NDA.
The generic ingredient in THIOSULFIL is sulfamethizole. There are four drug master file entries for this compound. Additional details are available on the sulfamethizole profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for THIOSULFIL?
- What are the global sales for THIOSULFIL?
- What is Average Wholesale Price for THIOSULFIL?
Summary for THIOSULFIL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 94 |
| Patent Applications: | 3,920 |
| DailyMed Link: | THIOSULFIL at DailyMed |
US Patents and Regulatory Information for THIOSULFIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Ayerst | THIOSULFIL | sulfamethizole | TABLET;ORAL | 008565-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wyeth Ayerst | THIOSULFIL | sulfamethizole | TABLET;ORAL | 008565-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
